原发性肝癌血管新生化和抗血管生成研究进展
摘要
原发性肝癌血管新生化与其生长浸润、转移、分期及预后密切相关 ,抑制肝癌血供的方法有望成为今后肝癌治疗的突破口。本文主要介绍了原发性肝癌新生的机制和抗血管生成策略的相关研究进展。
出处
《肝胆胰外科杂志》
CAS
2003年第4期277-279,共3页
Journal of Hepatopancreatobiliary Surgery
参考文献14
-
1[1]Hanahan D,Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis[J]. Cell,1996,86(3):353-364.
-
2[2]El-Assal ON,Yamanoi A,King M,et al. Clinical significance of microvessel density and Vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver:possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver[J]. Hepatology,1998,27(6):1554-1562.
-
3[3]Pak YN,Kin YB,Yang KM,et al. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis[J]. Arch Pattol Lab Med,2000,124(7):1061-1065.
-
4[4]El-Assel ON,Yamanoi A,ONo T,et al. The clinicopathological significance of heparanase and basin fibroblast growth factor expressions in hepatocellular carcinoma[J]. Chi Cancer Res,2001,7(5):1299-1305.
-
5[5]Guo L,Kuroda N,Toi M,et al . Increesed expression of platelet-derived endothelial cell growth factor in human hepatocellular carcinomas correlated with high edmondson grades and portal vein tumor thrombosis[J]. Oncol Rep,2001,8(4):871-876.
-
6[6]Jin-no K,Tanimizu M,Hyoho I,et al. Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients[J]. Cancer,1998,82(7):1260-1267.
-
7[7]Bae MH,Lee MJ,Bae SK,et al. Insuline-like growth factor Ⅱ secreted from HepG2 human hepato cellular carcinoma cells shows angiogenic activity[J]. Cancer Lett,1998,128(1):41-46.
-
8[8]Ueki T,Fwjimoto J,Suzuki T,et al . Expression of hepatolyte growth factor and its receptor,the C-met proto-oncogene,in hepato-cellular carcinoma[J]. Hepato Logy,1997,25(3):619-623.
-
9[9]Junbo H,Li Q,Zaide W,et al. Increased level of serum hepato-cyte growth factor/scatter factor in Liver cancer is associated with tumor metastasis[J]. In Vivo,1999,13(2):177-180.
-
10[10]Tanaka S,Mori M,Sakamoto Y,et al. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma[J]. J Clin Invest,1999,103(3):341-345.
-
1侯成功.胸苷磷酸化酶与肝癌血管新生及预后的关系[J].中国实用医刊,2011,38(15):121-123. 被引量：1
-
2刘维藩,柯昌能,李荣江,何义舟.胸苷磷酸化酶与肝癌血管新生及预后的关系[J].医师进修杂志（外科版）,2004,27(7):31-33.
-
3陈绪斌,陈绪安.胸苷磷酸化酶与肝癌血管新生及预后的关系[J].中国现代医生,2007,45(12Z):19-21.
-
4徐承平,张华蓉,陈飞兰,章容,卞修武.内皮祖细胞在胶质瘤新生血管中的募集和整合作用[J].重庆医学,2008,37(21):2424-2426. 被引量：4
-
5张冬,邹利光,王文献,文利,戴书华,孙清荣.星形细胞瘤MRI定量参数与微血管密度的关系[J].第三军医大学学报,2004,26(14):1308-1310.
-
6李晓东,曾进,黄海鹏,梅伟.血管新生抑制剂TNP-470对鼠ACHN肾细胞癌增殖与凋亡的影响[J].临床泌尿外科杂志,2003,18(8):490-491.
-
7阎萍,杨鹰.卵巢癌血管生成的研究进展[J].重庆医学,2006,35(15):1420-1422. 被引量：1
-
8刘兰.血管内皮生长因子对肿瘤血管生成影响的研究进展[J].中国病理生理杂志,2010,26(A10):2013-2013. 被引量：1
-
9张苏江.抗血管新生治疗在血液肿瘤中的应用[J].国外医学（输血及血液学分册）,2003,26(2):116-119. 被引量：4
-
10张建忠,李建业,田龙,张军晖,邢念增.前列腺癌TSP-1的表达与血管新生的关系及意义[J].临床泌尿外科杂志,2009,24(10):743-746.
